日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of T cell receptor-engineered T cells targeting the sarcoma-associated antigen papillomavirus binding factor

开发靶向肉瘤相关抗原乳头瘤病毒结合因子的T细胞受体工程化T细胞

Shuto Hamada ,Tomohide Tsukahara ,Yuto Watanabe ,Kenji Murata ,Yuka Mizue ,Terufumi Kubo ,Takayuki Kanaseki ,Yoshihiko Hirohashi ,Makoto Emori ,Munehide Nakatsugawa ,Atsushi Teramoto ,Toshihiko Yamashita ,Toshihiko Torigoe

Development of CAR-T cells specifically targeting cancer stem cell antigen DNAJB8 against solid tumours

针对实体瘤,开发特异性靶向癌症干细胞抗原DNAJB8的CAR-T细胞

Yuto Watanabe ,Tomohide Tsukahara ,Kenji Murata ,Shuto Hamada ,Terufumi Kubo ,Takayuki Kanaseki ,Yoshihiko Hirohashi ,Makoto Emori ,Atsushi Teramoto ,Munehide Nakatsugawa ,Toshihiko Yamashita ,Toshihiko Torigoe

Percutaneous Direct Puncture of Retropancreatic Splenic Vein and Portal Thrombectomy in a Patient With Liver Transplantation and Simultaneous Splenectomy

经皮直接穿刺胰后脾静脉及门静脉血栓切除术治疗肝移植联合脾切除术患者

Hara, Takanobu; Soyama, Akihiko; Ishimaru, Hideki; Matsushima, Hajime; Imamura, Hajime; Miyamura, Shuto; Hamada, Takashi; Matsuguma, Kunihito; Fukumoto, Masayuki; Tanaka, Takayuki; Adachi, Tomohiko; Hidaka, Masaaki; Eguchi, Susumu

Osteosarcoma-initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B

骨肉瘤起始细胞表现出较高的有氧糖酵解和 LIN28B 介导的氧化磷酸化的减弱

Emi Mizushima, Tomohide Tsukahara, Makoto Emori, Kenji Murata, Asuka Akamatsu, Yuji Shibayama, Shuto Hamada, Yuto Watanabe, Mitsunori Kaya, Yoshihiko Hirohashi, Takayuki Kanaseki, Munehide Nakatsugawa, Terufumi Kubo, Toshihiko Yamashita, Noriyuki Sato, Toshihiko Torigoe